OMERS Administration Corp’s Acadia Pharmaceuticals ACAD Stock Holding History

OMERS Administration Corp’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$848K	Hold	33,500	–	–	0.01%	729
2026 Q1	$746K	Buy	+33,500	New	+$801K	﹤0.01%	707
2025 Q4	–	Sell	-28,600	Closed	-$610K	–	1036
2025 Q3	$610K	Buy	+28,600	New	+$676K	﹤0.01%	684
2016 Q4	–	Sell	-92,400	Closed	-$2.94M	–	310
2016 Q3	$2.94M	Buy	92,400 +84,800	+1,116%	+$2.88M	0.05%	198
2016 Q2	$247K	Buy	+7,600	New	+$254K	0.01%	527

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OMERS Administration Corp's ACAD Position: Q2 2026 in Review

OMERS Administration Corp held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 33,500 shares worth $848K. The position accounts for 0.01% of the portfolio, ranked #729.

OMERS Administration Corp first reported a position in ACAD in Q2 2016 and has held it in 5 quarters since. The position peaked at $2.94M in Q3 2016. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

OMERS Administration Corp held 33,500 shares of Acadia Pharmaceuticals worth $848K as of Q2 2026.
OMERS Administration Corp left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up 0.01% of OMERS Administration Corp's portfolio in Q2 2026, its #729 holding.
OMERS Administration Corp first reported a position in Acadia Pharmaceuticals in Q2 2016 and has held it in 5 quarters since.
OMERS Administration Corp's Acadia Pharmaceuticals position peaked at $2.94M in Q3 2016.
354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.